liver cancer

Exelixis Hits Blockbuster Status
Exelixis Hits Blockbuster Status
Motley Fool
Exelixis
cabozantinib
Cabometx
kidney cancer
liver cancer
Cometriq
thyroid cancer
Flag link:
Bristol-Myers star Opdivo fails survival test in a matchup with Nexavar aimed at shaking up the big HCC market
Bristol-Myers star Opdivo fails survival test in a matchup with Nexavar aimed at shaking up the big HCC market
Endpoints
Bristol-Myers Squibb
Opdivo
Bayer
Nexavar
liver cancer
clinical trials
Flag link:
Lilly gets fifth use for Cyramza with FDA liver cancer nod
Lilly gets fifth use for Cyramza with FDA liver cancer nod
Pharmaforum
Eli Lilly
Cyramza
FDA
liver cancer
hepatocellular carcinoma
Flag link:
After a delay, Can-Fite digs into subpopulation data as liver cancer drug fails to hit primary endpoint
After a delay, Can-Fite digs into subpopulation data as liver cancer drug fails to hit primary endpoint
Fierce Biotech
Can-Fite BioPharma
liver cancer
namodenoson
clinical trials
Flag link:
Merck’s PhIII liver cancer study for Keytruda fails on two key endpoints, just three months after the FDA gave it the green light
Merck’s PhIII liver cancer study for Keytruda fails on two key endpoints, just three months after the FDA gave it the green light
Endpoints
Merck
Keytruda
clinical trials
liver cancer
Flag link:
Anti-rejection drug rapamycin shows promise in liver cancer
Anti-rejection drug rapamycin shows promise in liver cancer
Fierce Biotech
liver cancer
mTOR inhibitors
rapamycin
Flag link:
FDA approves Cabometyx for liver cancer
FDA approves Cabometyx for liver cancer
BioCentury
Exelixis
Ipsen
Cabometyx
liver cancer
FDA
Flag link:
Merck gets FDA okay for Keytruda as liver cancer therapy
Merck gets FDA okay for Keytruda as liver cancer therapy
Pharmaforum
Merck
Keytruda
FDA
hepatocellular carcinoma
liver cancer
Flag link:
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
CP Wire
China
Eisai
Merck
Lenvima
liver cancer
HCC
Flag link:
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
Eisai
Merck
Lenvima
liver cancer
hepatocellular carcinoma
Flag link:
Death rate from liver cancer skyrockets
Death rate from liver cancer skyrockets
WWSB
liver cancer
CDC
Flag link:
Japan's Eisai sets price tag of about $16,000 on liver cancer drug
Japan's Eisai sets price tag of about $16,000 on liver cancer drug
Yahoo/Reuters
Eisai
liver cancer
drug pricing
Lenvima
Flag link:
FDA stalls Eisai—and its new partner Merck—in quest to widen cancer med Lenvima's reach
FDA stalls Eisai—and its new partner Merck—in quest to widen cancer med Lenvima's reach
Fierce Pharma
Merck
Eisai
Lenvima
liver cancer
FDA
Flag link:
Lilly's Cyramza succeeds in late-stage liver cancer trial
Lilly's Cyramza succeeds in late-stage liver cancer trial
Yahoo/Reuters
Eli Lilly
Cyramza
liver cancer
clinical trials
Flag link:
Bristol-Myers' I-O star Opdivo steps up to challenge Bayer's Stivarga in liver cancer
Bristol-Myers' I-O star Opdivo steps up to challenge Bayer's Stivarga in liver cancer
Fierce Pharma
Bristol-Myers Squibb
Opdivo
Bayer
Stivarga
liver cancer
Flag link:
Eisai's Lenvima nabs survival edge in liver cancer showdown with Bayer's Nexavar
Eisai's Lenvima nabs survival edge in liver cancer showdown with Bayer's Nexavar
Fierce Pharma
Eisai
Lenvima
liver cancer
Bayer
Nexavar
ASCO 2017
Flag link:
Bayer's Stivarga Shows Slim Progress Against Liver Cancer
Bayer's Stivarga Shows Slim Progress Against Liver Cancer
Forbes
Bayer
Stivarga
liver cancer
Flag link:
Daiichi, ArQule cancer drug fails in late-stage study
Daiichi, ArQule cancer drug fails in late-stage study
BioPharma Dive
Daiichi Sankyo
Arqule
clinical trials
tivantinib
liver cancer
Flag link:
Bayer growth hope Stivarga boosts survival in liver cancer patients
Bayer growth hope Stivarga boosts survival in liver cancer patients
Fierce Pharma
Bayer
Stivarga
liver cancer
Nexavar
hepatocellular carcinoma
Flag link:
Bayer's Stivarga shows efficacy in liver cancer
Bayer's Stivarga shows efficacy in liver cancer
BioPharma Dive
Bayer
Stivarga
liver cancer
Flag link:

Pages